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Objectives. We sought to determine the importance of nitric
oxide (NO) production in maintaining coronary blood flow during
exercise in hearts with collateral-dependent myocardium.
Background. Coronary collateral vessels demonstrate endo-
thelium-mediated NO-dependent vasodilation in response to ago-
nists such as acetylcholine. However, the contribution of endoge-
nous NO production to maintaining vasodilation of coronary
collateral vessels during exercise has not been previously studied.
Methods. Collateral vessel growth was induced in 13 chroni-
cally instrumented dogs by intermittent 2-min occlusions, fol-
lowed by permanent occlusion of the left anterior descending
coronary artery (LAD). One week after permanent LAD occlusion,
myocardial blood flow was measured with microspheres during
rest and treadmill exercise at 6.4 km/h at a 15% grade. Measure-
ments were then repeated after blockade of NO production with
N-nitro-L-arginine (LNNA) (20 mg/kg body weight intravenously).
Results. LNNA caused a 62 6 4% (mean 6 SEM) inhibition of
the coronary vasodilation produced by acetylcholine. During rest
conditions, LNNA caused a slight decrease in blood flow to the
collateral region (p 5 NS), with no change in normal zone blood
flow. During exercise, LNNA caused a decrease in mean blood flow
to the collateral region (from 2.24 6 0.19 to 1.78 6 0.26 ml/min
per g after LNNA, p < 0.05). This decrease resulted from a near
doubling of the collateral vascular resistance (p < 0.05), with a
trend toward an increase in small vessel resistance in the collat-
eral zone. LNNA also reduced myocardial blood flow to the
normal region during exercise (from 2.99 6 0.24 to 2.45 6
0.28 ml/min per g, p < 0.05) as the result of a 44 6 13% increase
in coronary vascular resistance (p < 0.05).
Conclusions. NO contributes to the maintenance of coronary
collateral blood flow during exercise. In contrast to the normal
heart, endogenous NO production also maintains blood flow in
remote myocardial regions during exercise. These results suggest
that control of blood flow during exercise in normal myocardium
is altered by the presence of an occluded coronary artery.
(J Am Coll Cardiol 1998;31:67–74)
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The coronary endothelium produces a diverse group of bio-
logically active substances that can modulate vasomotor tone.
Among the most important of these is nitric oxide (NO), which
is produced from L-arginine by endothelial NO synthase. NO
has been shown to mediate the vasodilator responses to several
endothelium-dependent agonists, including acetylcholine (1)
and bradykinin (2), and is responsible for flow-mediated
coronary artery vasodilation that occurs during exercise in
response to increased endothelial shear stress (3).
When occlusive coronary artery disease occurs gradually,
collateral vessels develop to protect the myocardium distal to
the obstruction. These collateral vessels may supply sufficient
blood flow to meet the metabolic requirement of the depen-
dent myocardium at rest, but they can become flow-limiting
during periods of increased demands, resulting in angina
pectoris or left ventricular dysfunction during exercise. In vitro
studies using isolated vessel rings have demonstrated that
collateral vessels acquire a functionally competent endothe-
lium and muscular media early in their development and are
responsive to NO-dependent agonists, such as bradykinin and
acetylcholine (4–6). Inhibition of NO synthesis has been
shown to decrease retrograde blood flow from a cannulated
collateral-dependent coronary artery in anesthetized open
chest dogs (7) and to significantly increase collateral vessel
vascular resistance in awake dogs (8), demonstrating that tonic
production of NO maintains collateral vasodilation. However,
it is not known whether NO-mediated vasodilation contributes
to the maintenance of collateral blood flow in the intact animal
during exercise. Previous studies have failed to demonstrate an
obligatory requirement for NO production during exercise in
the normal heart because blockade of NO synthesis with
N-nitro-L-arginine (LNNA) did not impair the normal increase
in coronary blood flow in response to exercise (9). Although
inhibition of NO production does not affect basal coronary
blood flow in the normal heart, it does cause constriction of
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epicardial coronary arteries (10). The collateral vessels that
develop in response to coronary occlusion represent a major
locus of resistance to blood flow into the dependent myocar-
dium. Furthermore, responses of collateral vessels to vasoac-
tive agonists more closely resemble those of epicardial coro-
nary arteries than resistance vessels. Consequently, the present
study was performed to test the hypothesis that inhibition of
NO production would impair coronary collateral blood flow
during exercise.
Methods
Studies were carried out in 18 adult mongrel dogs weighing
25 to 30 kg, trained to run on a motor-driven treadmill. All
studies were performed in accordance with the “Position of the
American Heart Association on Research Animal Use”
adopted by the Association in November 1984 and were
approved by the Animal Care Committee of the University of
Minnesota.
Surgical preparation. Animals were premedicated with
acepromazine (10 mg intramuscularly), anesthetized with so-
dium pentobarbital (30 to 35 mg/kg body weight intravenous-
ly), intubated and ventilated with room air supplemented with
oxygen. A left thoracotomy was performed in the fifth inter-
costal space. A heparin-filled polyvinyl chloride catheter,
3.0-mm outer diameter, was introduced into the internal
thoracic artery and advanced until the tip was positioned in the
ascending aorta. The pericardium was then opened and the
heart suspended in a pericardial cradle. A second catheter was
placed into the left atrium through the appendage and secured
with a purse-string suture. A similar catheter was introduced
into the left ventricle at the apical dimple and secured in place.
A bipolar pacing electrode was sutured to the right atrial
appendage. The proximal left anterior descending coronary
artery (LAD) was dissected free, and a Doppler velocity probe
(Craig Hartley) was placed around the vessel. A hydraulic
occluder and snare-type occluder were positioned around the
artery distal to the velocity probe. A heparin-filled silicone
rubber catheter (0.3-mm inner diameter) was placed into the
artery distal to the occluders (11). The pericardium was then
loosely closed, and the catheters and electrical leads were
tunneled subcutaneously to exit at the base of the neck. The
thoracotomy was closed in layers and the chest evacuated of
air. Catheters were protected with a nylon vest and were
flushed daily with heparinized saline to maintain patency.
Induction of collateral vessel growth. One week after
operation, 13 of the dogs were returned to the laboratory for
initiation of collateral vessel development using a modification
of the repetitive coronary occlusion technique of Franklin et al.
(12). While distal coronary pressure was measured, the hydrau-
lic occluder was inflated with saline; the flowmeter signal was
monitored to ensure total occlusion. Initial distal coronary
pressures during occlusion were 10 to 20 mm Hg in all dogs. A
protocol of coronary occlusions 2 min in duration performed at
15-min intervals 3 h each day was then begun 5 days/week.
When distal coronary pressure during occlusion exceeded
35 mm Hg (2 to 3 weeks after beginning the coronary occlusion
protocol), the artery was permanently occluded by tightening
the snare occluder. We have previously observed (13) that
sufficient collateral blood flow is present at this pressure to
prevent infarction. Studies were performed 5 to 7 days after
permanent coronary occlusion, when distal coronary pressure
routinely exceeded 70 mm Hg and rest collateral blood flow is
not significantly different from normal zone blood flow.
Measurement of myocardial blood flow. Myocardial blood
flow during exercise was measured in seven dogs with 15-mm
diameter microspheres labeled with cesium-141, chromium-51,
strontium-85, niobium-95 or scandium-46 (NEN Co.). In six
dogs, measurements of rest myocardial blood flow before and
after LNNA were made with 15-mm diameter fluorescent
microspheres. Microspheres were obtained as 1.0 mCi in 10-ml
low molecular weight dextran. For each measurement, 3 3 106
microspheres were injected into the left atrium and flushed
with normal saline. A reference sample of arterial blood was
obtained from the aortic catheter at a constant rate of
15 ml/min using a peristaltic pump beginning at the time of
microsphere injection and continuing for 90 s.
Effect of NO blockade on myocardial blood flow during
exercise (group 1). Aortic, left ventricular and distal coronary
pressures were measured with pressure transducers (Spec-
tramed model TNF-R) at midchest level. Left ventricular
pressure was recorded both at normal and at high gain for
measurement of end-diastolic pressure. Data were recorded on
an eight-channel direct writing recorder (Coulbourne Instru-
ments). After all recording instruments were connected, a
5-min period of warm-up exercise was performed while the
exercise intensity was gradually increased to 6.4 km/h at a 15%
grade. Heart rate was controlled during the subsequent exer-
cise protocols by atrial pacing at a rate 10 to 20 beats/min faster
than the sinus rate recorded during this warm-up exercise. The
dogs were then allowed to rest for 1 h. Control rest hemody-
namic measurements were then obtained with the dogs stand-
ing quietly on the treadmill. After obtaining rest measure-
ments, exercise was begun at 6.4 km/h at a 15% grade.
Hemodynamic measurements were recorded continuously to
ensure that steady state conditions existed. Three minutes after
beginning exercise, microspheres were injected into the left
atrium for measurement of myocardial blood flow. The ani-
Abbreviations and Acronyms
ENDO 5 subendocardial blood flow
EPI 5 subepicardial blood flow
LAD 5 left anterior descending coronary artery
LNAME 5 N-nitro-L-arginine methyl ester
LNMMA 5 L-monomethyl arginine
LNNA 5 N-nitro-L-arginine
NO 5 nitric oxide
NOS 5 nitric oxide synthase
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mals continued to exercise for 2 min after the microsphere
injection.
Dogs were then allowed to rest quietly on the treadmill for
1 h. During this time, N-nitro-L-arginine (LNNA) dissolved in
normal saline in a dose of 20 mg/kg was infused into the left
atrium over 30 min. All hemodynamic measurements were
again recorded, and the exercise protocol was repeated at the
identical exercise level and pacing rate used during control
conditions. Hemodynamic measurements and microsphere ad-
ministration were performed 3 min after beginning exercise,
and exercise continued for 2 min after microsphere injection.
Effect of NO blockade on rest myocardial blood flow (group
2). The effect of inhibition of NO production on rest myocar-
dial blood flow was assessed in a separate group of six dogs that
underwent the identical surgical instrumentation and induction
of collateral vessel development. With the dogs standing
quietly in a sling, rest blood flow to the normal and collateral-
dependent myocardium was measured with fluorescent micro-
spheres. LNNA (20 mg/kg) was infused into the left atrium
over 30 min, and blood flow measurements were repeated
30 min later.
Identification of collateral-dependent myocardium. The
region of collateral-dependent myocardium was identified by
the shadow technique of Patterson and Kirk (14). After
completion of the exercise protocol, dogs were premedicated
with morphine sulfate (2 mg/kg intramusculary), anesthetized
with alpha-chloralose (100 mg/kg intravenously, followed by an
infusion of 10 mg/kg per h), intubated and ventilated with a
respirator. A left thoracotomy was performed in the sixth
intercostal space, and the proximal LAD was dissected free
and cannulated with a thin-walled stainless steel cannula at the
site of the snare occluder. A 26-gauge tube incorporated into
the cannula allowed measurement of cannula tip pressure. The
cannula was then perfused with nonradioactive arterial blood
from a reservoir pressurized to maintain cannula tip pressure
10 to 15 mm Hg above mean aortic pressure while radioactive
microspheres were injected into the left atrium. Using this
technique, the collateral-dependent region was perfused with
nonradioactive blood while the normal region was perfused
with blood containing microspheres. The dogs were killed with
pentobarbital, and the heart and kidneys were removed and
placed into 10% buffered formalin.
After fixation, the left ventricle was separated from the
atrium and right ventricle, and the epicardial vessels and fat
were trimmed away. The left ventricle was then sectioned into
five transverse rings from base to apex and inspected to ensure
the absence of infarct. Each ring was then sectioned into 16
radial segments that were divided into epicardial and endocar-
dial halves, weighed and placed into vials for counting. Myo-
cardial and blood reference specimens were counted in a
gamma-spectrometer (model 5912, Packard Instrument Co.) at
window settings corresponding to the peak energies of each
radionuclide. The activity in each energy window was corrected
for background and overlapping counts between isotopes with
a digital computer. Blood flow to each myocardial specimen
(Qm) was computed using the formula Qm 5 QrzCm/Cr, where
Qr is the reference blood flow rate (ml/min), Cm is counts/min
of the myocardial specimen, and Cr is counts/min of the
reference blood specimen. Collateral-dependent myocardium
was identified as specimens having blood flow rates during the
shadow injection .3 SD below the mean value of flow of the
samples obtained from the normally perfused region.
Myocardial specimens and reference blood samples con-
taining fluorescent microsphere were processed using the
method of Glenny et al. (15). Tissue was weighed and then
digested in 4N KOH in a heated 50°C bath for 48 h. Micro-
spheres were recovered in 10 mm filters after vacuum filtration.
The microspheres were digested in 2-ethoxy-ethyl acetate.
Fluorescence measurements were made with a fluorescent
spectrophotometer (Perkin Elmer Co.) using a FAC7 software
package (Fluorescent Microsphere Resource Center, Univer-
sity of Washington). Myocardial blood flow was calculated in
the same manner as with radioactive microspheres.
Degree of blockade of endothelium-dependent vasodilation.
Responses of coronary blood flow to endothelium-dependent
and independent vasodilators could not be directly assessed in
our model because permanent occlusion of the collateral-
dependent artery prevented intraarterial administration of
agonist. Consequently, to assess the ability of LNNA to inhibit
endothelium-dependent, NO-mediated vasodilation, five addi-
tional dogs with the identical surgical instrumentation but
without coronary occlusion were studied. With the dogs stand-
ing quietly in a sling, LAD coronary artery blood flow was
measured with a Doppler velocity probe. Acetylcholine dis-
solved in normal saline was infused into the coronary artery
catheter at rates of 1.5, 3.75, 7.5 and 15 mg/min (infusion rates
between 0.15 to 1.5 ml/min). Coronary blood flow was re-
corded continuously during each infusion, and measurements
were taken after blood flow had achieved a steady state.
Normal saline was infused at the same rates to determine the
effect of vehicle on coronary blood flow. Thirty minutes later,
the response to the endothelium-independent vasodilator so-
dium nitroprusside infused into the coronary artery at rates of
0.6, 1.5 and 3.0 mg/kg per min was examined. LNNA at a dose
of 20 mg/kg was then infused into the left atrium over 30 min.
The responses to acetylcholine and sodium nitroprusside were
again measured beginning 30 min after administration of
LNNA.
Data analysis. Heart rate and pressures were measured
directly from the strip-chart recordings. Transcollateral vessel
resistance was calculated as the pressure drop from mean
aortic pressure to pressure in the LAD coronary artery distal to
the occlusion divided by mean collateral zone blood flow.
Small vessel resistance in the collateral-dependent region was
calculated as (Distal coronary pressure 2 Left ventricular
end-diastolic pressure)/Mean collateral zone blood flow. Total
vascular resistance in the normal zone was calculated as (Mean
aortic pressure 2 Left ventricular end-diastolic pressure)/
Mean normal zone blood flow. Resistance calculations were
expressed as mm Hgzml21zminzg. In one animal, measurement
of left ventricular end-diastolic pressure could not be obtained
and was not included in the calculation of resistance.
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For dogs in which dose–response curves to acetylcholine
and sodium nitroprusside were obtained, the coronary Dopp-
ler shift in kHz was converted to blood flow using the equation
q 5 2.5 3 d2 3 f, where q is coronary blood flow in ml/min, d
is the internal diameter of the vessel in mm, and f is the
Doppler frequency shift measured in kHz (16). Because the
artery becomes adherent to the flow probe after operation,
coronary artery diameter is fixed at the site where the velocity
signal is obtained so that the external diameter of the artery is
equal to the internal diameter of the flow probe. Based on
previous observations, the internal diameter of the artery was
taken as 80% of its external diameter.
Data were compared within individual groups using analysis
of variance for repeated measures; a value of p , 0.05 was
required for statistical significance. When a statistically signif-
icant result was found, individual comparisons were performed
using the Wilcoxon signed-rank test with a Bonferroni correc-
tion. Data are expressed as mean value 6 SEM.
Results
Group 1: response to NO blockade during exercise. Hemo-
dynamic data. Hemodynamic data during treadmill exercise
before and after administration of LNNA in the seven dogs in
group 1 are shown in Table 1. Both mean aortic pressure and
peak left ventricular systolic pressure increased significantly in
response to LNNA. Heart rate was maintained constant by
atrial pacing. Distal coronary pressure during exercise was
unchanged after administration of LNNA, whereas the
transcollateral pressure gradient increased from 43 6 3 to 60 6
7 mm Hg (p , 0.08).
Myocardial blood flow during exercise. Left ventricular mass
ranged from 79 to 158 g (mean 114 6 9). The mass of
collateral-dependent myocardium ranged from 19.6 to 37.1 g
(mean 25.8 6 2.2) and comprised 23.3 6 2.2% of the left
ventricle. Myocardial blood flow measurements are shown in
Tables 2 and 3. Mean myocardial blood flow in the normal
zone during control exercise was 2.99 6 0.24 ml/min per g and
decreased to 2.45 6 0.28 ml/min per g after NO synthase
(NOS) inhibition with LNNA (p , 0.05). This decrease in
blood flow in response to LNNA was uniform throughout all
regions of the normal zone. When blood flow was examined by
layers, subendocardial blood flow (ENDO) was significantly
higher than subepicardial blood flow (EPI) during control
exercise (p , 0.05), with an ENDO/EPI flow ratio of 1.15 6
0.04 during control exercise. The ENDO/EPI blood flow ratio
was unchanged during exercise after LNNA.
Mean myocardial blood flow to the collateral-dependent
region was 2.24 6 0.19 ml/min per g during control exercise
and was significantly lower than normal zone blood flow (p ,
0.05). After LNNA, mean blood flow in the collateral-
dependent region decreased by 20 6 7% (p , 0.05). When
blood flow was examined by layers, there was a tendency
toward a greater decrease in subendocardial flow than in
subepicardial flow in the collateral zone (ENDO/EPI flow ratio
decreased from 1.02 6 0.06 to 0.89 6 0.07 after LNNA, p ,
0.07).
Coronary vascular resistance values are shown in Table 3
and Figures 1 and 2. After LNNA, the aortic to distal coronary
pressure gradient during exercise increased by 42 6 15% (p ,
0.05), and blood flow significantly decreased, resulting in a
near doubling of the transcollateral resistance (p , 0.05).
Small vessel resistance in the collateral zone tended to increase
after LNNA but did not achieve statistical significance (Fig. 1).
Coronary vascular resistance in the normal zone (Fig. 2), which
reflects the contributions of both conduit and resistance ves-
sels, increased by 44 6 13% during exercise after LNNA (p ,
0.05).
Table 2. Myocardial Blood Flow and Subendocardial/Subepicardial Blood Flow Ratio in Normal and
Collateral-Dependent Myocardium During Exercise
Normal Region Blood Flow
(ml/min per g)
Collateral Region Blood Flow
(ml/min per g)
ENDO EPI ENDO/EPI ENDO EPI ENDO/EPI
Control 3.19 6 0.24 2.81 6 0.25* 1.15 6 0.04 2.23 6 0.17† 2.25 6 0.23† 1.02 6 0.06†
LNNA 2.63 6 0.29‡ 2.29 6 0.27*‡ 1.16 6 0.05 1.69 6 0.30†‡ 1.87 6 0.24†‡ 0.89 6 0.07§†
*p , 0.05 versus subendocardial blood flow (ENDO). †p , 0.05 versus normal region. ‡p , 0.05, §p , 0.07 versus
control. Data presented are mean value 6 SEM. EPI 5 subepicardial blood flow; LNNA 5 N-nitro-L-arginine.
Table 1. Hemodynamic Measurements During Treadmill Exercise Before and After Administration of
N-Nitro-L-Arginine
HR
(beats/min)
Mean Aortic
Pressure
(mm Hg)
RPP
(mm Hgzbeats/min)
LV dP/dt
(mm Hg/s)
LVEDP
(mm Hg)
Distal Coronary
Pressure
(mm Hg)
Control 230 6 9 119 6 6 33,700 6 1,900 5,660 6 770 13 6 3 76 6 7
LNNA 227 6 11 136 6 4* 38,700 6 700* 5,030 6 700 17 6 5 76 6 8
*p , 0.05, control versus N-nitro-L-arginine (LNNA). Data presented are mean value 6 SEM. HR 5 heart rate;
LV 5 left ventricular; LVEDP 5 left ventricular end-diastolic pressure; RPP 5 rate–pressure product.
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Group 2: response to NO blockade at rest. Responses to
LNNA in six awake dogs at rest are shown in Table 4. LNNA
caused a significant increase in aortic pressure and a significant
decrease in heart rate. During control conditions, blood flow
tended to be less in the collateral zone than in the normally
perfused region and was of borderline significance (p , 0.08).
Blood flow in the collateral-dependent region decreased from
1.20 6 0.17 to 0.94 6 0.10 ml/min per g in response to LNNA
but did not achieve statistical significance (p 5 0.18). The trend
toward a decrease in collateral zone blood flow in conjunction
with the increase in arterial pressure in response to LNNA
resulted in a 65 6 26% increase in vascular resistance (p ,
0.07). Mean myocardial blood flow at rest in the normal zone
was 1.35 6 0.19 ml/min per g during control conditions and was
unchanged after LNNA.
Effect of LNNA on coronary responses to acetylcholine and
sodium nitroprusside. Coronary blood flow responses to in-
tracoronary infusions of acetylcholine and sodium nitroprus-
side before and after LNNA in five normal dogs are shown in
Figure 3. Heart rate was 119 6 7 beats/min, and mean aortic
pressure was 96 6 3 mm Hg during control conditions.
Intracoronary infusions of acetylcholine and sodium nitroprus-
side had no effect on heart rate or arterial pressure. Infusion of
vehicle did not change coronary blood flow. Baseline coronary
blood flow was 44 6 3 ml/min and increased to 89 6 12 ml/min
in response to the largest dose of acetylcholine (15 mg/min)
and to 110 6 13 ml/min in response to the largest dose of
sodium nitroprusside (3.0 mg/kg per min). After administration
of LNNA, mean aortic pressure rose to 125 6 11 mm Hg, and
heart rate fell to 101 6 9 beats/min (both p , 0.05). LNNA
significantly blunted the response of coronary blood flow to
acetylcholine, with 62 6 4% inhibition of the increase in
coronary blood flow caused by acetylcholine at a dose of 15
mg/min (p , 0.01). In contrast, LNNA had no effect on the
increase in coronary flow produced by sodium nitroprusside.
Discussion
The results of the present study indicate that NO produc-
tion contributes to the maintenance of blood flow to collateral-
dependent myocardium during exercise. Inhibition of NO
production by LNNA resulted in a near doubling of the
transcollateral resistance during exercise. Furthermore, small
vessel resistance in the collateral zone failed to decrease after
LNNA at a time when the fall in tissue blood flow might have
been expected to cause metabolic vasodilation. Although
LNNA caused no change in normal zone blood flow during rest
conditions, it significantly decreased blood flow during exer-
cise. This result is in contrast to previous studies in which
LNNA did not decrease coronary blood flow during exercise in
the normal heart (9) and suggests that control of vasomotor
tone is altered in remote regions of normal myocardium after
chronic coronary artery occlusion. The possible mechanisms
and implications of these changes caused by blockade of NO
synthesis are discussed in detail.Figure 1. Transcollateral vascular resistance and small vessel resis-
tance in the collateral zone during control exercise and after admin-
istration of LNNA in each dog. Transcollateral resistance was calcu-
lated as (Aortic pressure 2 Distal coronary pressure)/(Mean
myocardial blood flow in the collateral region). Small vessel resistance
was calculated as (Distal coronary pressure 2 Left ventricular end-
diastolic pressure)/(Mean myocardial blood flow in the collateral
region). Mean responses and standard errors are shown.
Figure 2. Coronary vascular resistance in the normal region during
control exercise and after administration of LNNA in each animal.
Normal zone resistance was calculated as (Aortic pressure 2 Left
ventricular end-diastolic pressure)/(Mean myocardial blood flow in the
normal zone). Mean responses and standard errors are shown.
Table 3. Mean Myocardial Blood Flow and Coronary and Collateral Vascular Resistance During Exercise
Mean Aortic
Pressure
(mm Hg)
Distal Coronary
Pressure
(mm Hg)
Aortocoronary
Pressure
Gradient
(mm Hg)
Normal Zone Collateral Zone
Mean Myocardial
Blood Flow
(mlzmin21zg21)
Coronary Vascular
Resistance
(mm Hgzml21zminzg)
Mean Myocardial
Blood Flow
(mlzmin21zg21)
Transcollateral
Resistance
(mm Hgzml21zminzg)
Small Vessel
Vascular Resistance
(mm Hgzml21zminzg)
Control 119 6 6 76 6 7 43 6 3 2.99 6 0.24 37.2 6 4.5 2.24 6 0.19* 19.9 6 1.8 29.5 6 4.9
LNNA 136 6 4‡ 76 6 8 60 6 7† 2.45 6 0.28‡ 53.7 6 8.4‡ 1.78 6 0.26*‡ 38.4 6 7.4‡ 37.5 6 8.4
*p , 0.05 versus normal zone blood flow. †p , 0.08, ‡p , 0.05 versus control. Data presented are mean value 6 SEM. LNNA 5 N-nitro-L-arginine.
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Endothelium-dependent coronary vasodilation. Previous
studies have documented that endogenous NO can influence
coronary vasomotor tone in the normal heart. Chu et al. (10)
found that blocking NO synthesis with L-monomethyl arginine
(LNMMA) produced dose-related decreases in epicardial cor-
onary artery diameter but had little effect on rest coronary
blood flow in awake dogs. Jones et al. (17) observed that
N-nitro-L-arginine methyl ester (L-NAME) caused constriction
of small arteries but compensatory vasodilation of arterioles,
resulting in preservation of coronary blood flow. Parent et al.
(18) demonstrated that the increase in coronary blood flow
produced by acetylcholine in dogs was attenuated by LNNA
and was partially restored after administration of L-arginine.
These results were specific for endothelium-dependent vaso-
dilation because the response to the endothelium-independent
vasodilator nitroglycerin was unchanged by LNNA. Komaru et
al. (19) used intravital microscopy to study the effect of NO
production in the microcirculation of open chest dogs. Acetyl-
choline produced dose-dependent vasodilation of small arter-
ies (.120 mm) and arterioles (,120 mm). The response to
acetylcholine was completely inhibited by LNMMA in the
small arteries but was only partially blocked in the arterioles, in
agreement with our findings that demonstrated incomplete
inhibition of the coronary blood flow response to acetylcholine
by LNNA and suggests that other vasodilator substances not
derived from L-arginine, such as the endothelium-derived
hyperpolarizing factor (20), may also be involved in the
vasodilator response to acetylcholine. In addition to agonist-
mediated, endothelium-dependent vasodilation, Kuo et al.
(21) demonstrated that flow-mediated vasodilation also occurs
in isolated porcine coronary resistance vessels (40 to 80 mm).
This response is dependent on the production of NO because
dilation was abolished by LNMMA.
Endothelial function in collateral vessels. In studies of
preconstricted rings of epicardial collateral vessels obtained 12
weeks after placement of an ameroid constrictor on the LAD
of dogs, Flynn et al. (6) found that both acetylcholine and
bradykinin produced dose-dependent relaxation that was at-
tenuated by inhibition of NO synthesis with LNMMA. Angus
et al. (5) observed that acetylcholine caused equivalent relax-
ation of preconstricted rings of collateral vessels and normal
coronary artery segments of similar size obtained from dogs 6
months after ameroid occlusion of the left circumflex coronary
artery. Altman et al. (4) examined responses of retrograde
blood flow from the cannulated collateralized LAD 4 to 6
months after coronary artery occlusion. Both acetylcholine and
bradykinin significantly increased collateral blood flow; the
increase in collateral flow was equivalent to that produced by
nitroglycerin, a known potent vasodilator of coronary collat-
eral vessels. Frank et al. (8) demonstrated that NO production
is important in maintaining tonic collateral vasodilation in
awake dogs at rest. In that study, LNNA caused a significant
increase in coronary collateral vascular resistance that was
accompanied by a small decrease in collateral zone blood flow
at rest. These results are in agreement with our findings in
which LNNA tended to decrease rest collateral zone blood
flow at rest. Overall, these studies indicate that endothelium-
dependent vasodilator mechanisms acting through NO con-
tribute to maintenance of collateral vessel dilation during rest
conditions.
The importance of NO in maintaining collateral blood flow
during exercise has not been previously studied. The collateral
vasoconstriction that occurred after administration of LNNA
in the present study most likely resulted from inhibition of
tonic and flow-mediated release of NO. The increase in blood
flow through the collateral vessels during exercise would be
expected to augment shear stress on the endothelial cells. In
canine epicardial coronary arteries, an increase in shear results
in vasodilation through release of NO (3). Although the
response of collateral vessels to increasing shear has not been
studied, the increase in blood flow during exercise would most
likely also result in shear-mediated vasodilation of the collat-
eral vessels.
Figure 3. Changes (mean 6 SEM) in blood flow in the LAD in
response to intracoronary (i.c.) administration of the endothelium-
dependent vasodilator acetylcholine and the endothelium-independent
vasodilator sodium nitroprusside before (solid circles) and after
LNNA (open circles). LNNA inhibited the increase in coronary blood
flow produced by acetylcholine but not by sodium nitroprusside.
Table 4. Hemodynamic Variables and Mean Myocardial Blood Flow During Rest (group 2)
Mean Aortic
Pressure
(mm Hg)
HR
(beats/min)
LVSBP
(mm Hg)
LVEDP
(mm Hg)
Blood Flow
Normal Zone
(ml/min per g)
Normal Zone
Vascular Resistance
(mm Hgzmin/ml)
Blood Flow
Collateral Zone
(ml/min per g)
Collateral Zone
Vascular Resistance
(mm Hgzmin/ml)
Control 96 6 4 140 6 6 128 6 3 6 6 1 1.35 6 0.19 75.4 6 11.8 1.20 6 0.17* 80 6 4
LNNA 122 6 5† 110 6 7† 143 6 7† 11 6 2* 1.36 6 0.32 99.6 6 15.6† 0.94 6 0.10* 130 6 7†
*p , 0.08 versus normal zone blood flow. †p , 0.05 versus control. Data presented are mean value 6 SEM. SBP 5 systolic blood pressure; other abbreviations
as in Table 1.
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Response of resistance vessels in the collateral zone during
exercise. Mean myocardial blood flow in the collateral-
dependent region was ;75% of normal zone blood flow during
control exercise. This disparity in blood flow was not unex-
pected because the study was performed relatively early during
collateral vessel development. However, our findings suggest
that impaired vasodilation of the small vessels in the collateral
region also contributed to the observed hypoperfusion because
distal coronary pressure failed to decrease below its rest value
during exercise. This finding suggests that metabolic vasodila-
tion in the collateral region was impaired during exercise and
is in agreement with previous studies that have demonstrated
reduced receptor-mediated, endothelium-dependent vasodila-
tion in the microvessels of collateral-dependent myocardium (22).
LNNA caused a significant increase in the rate–pressure
product during exercise, implying increased myocardial oxygen
demands. An increase in metabolic demands, in conjunction
with the collateral constriction produced by LNNA would be
expected to cause metabolic vasodilation of the resistance
vessels in the collateral zone. However, this did not occur;
small vessel resistance was actually 21 6 10% higher after
LNNA than during control exercise. Because heart rate and
left ventricular diastolic pressures were unchanged from con-
trol exercise, the decrease in collateral zone blood flow during
exercise after LNNA most likely reflects impaired NO produc-
tion rather than metabolic or hemodynamic influences on
myocardial perfusion. In addition to a direct coronary vasodi-
lator effect during exercise, NO has been shown to contribute
to beta-adrenergic vasodilation of coronary resistance vessels
(23). Blocking NO production could thus impair beta-
adrenergic vasodilation resulting from sympathetic venous
system activation during exercise. Furthermore, impaired beta-
adrenergic vasodilation could unmask alpha-adrenergic vaso-
constriction in the coronary resistance vessels during exercise.
Effect of NO inhibition on blood flow to normal myocar-
dium during exercise. Inhibition of NO production by LNNA
resulted in a significant decrease in normal zone flow during
exercise. This finding was unexpected because previous studies
have failed to demonstrate an obligatory role for NO produc-
tion in maintaining coronary blood flow during exercise in the
normal heart (9). The results suggest that inhibition of NO
production in collateralized hearts unmasks an impairment of
resistance vessel dilation during exercise in the remote normal
region. It is possible that repetitive episodes of ischemia in the
LAD territory during collateral development could induce
changes in the resistance vessels of the normal region. Lust et
al. (24) observed that vasodilator responses to acetylcholine
and adenosine were significantly reduced in LAD epicardial
artery segments 3 h after circumflex occlusion, whereas the
responses to endothelium-independent vasodilators were un-
altered. Further support for the influence of regional ischemia
on remote regions was demonstrated by Przyklenk et al. (25) in
preconditioning experiments. They observed that brief periods
of ischemia in one territory conferred protection in remote
regions during a subsequent occlusion. The mechanism by
which regional ischemia can influence remote regions is not
known, but might involve the production of catecholamines or
heightened sympathetic tone (26). Because NO has been
demonstrated to contribute to beta-adrenergic vasodilation of
coronary resistance vessels (23), it is possible that the increase
in sympathetic activation during exercise coupled with im-
paired beta-adrenergic receptor-mediated vasodilation after
LNNA could unmask alpha-adrenergic vasoconstriction,
thereby causing a reduction in myocardial blood flow in the
normal region.
Although the microvessels in the normal region are the
major determinant of coronary vascular resistance, it is possi-
ble that the contribution of the conduit vessels to total
coronary resistance is increased in this model. After occlusion
of the proximal LAD, the dependent myocardium derives its
blood supply principally from collateral vessels originating
from the circumflex and septal arteries, with a small contribu-
tion from the right coronary artery (27). Consequently, the
circumflex and septal arteries must conduct sufficient addi-
tional blood flow to maintain perfusion of the collateralized
region. Longhurst et al. (28) measured myocardial blood flow
during exercise in dogs 2 months after placement of an
ameroid constrictor on the left circumflex artery. During
moderately heavy exercise, the increases in both normal zone
and collateral zone blood flow were significantly less in the
ameroid group than in a sham-operated control group. They
concluded that the limited conductance of the conduit vessels
supplying the left ventricle impaired blood flow to the normal
region during exercise. Because our animals were studied at an
earlier phase of collateral development that resulted in lower
flow rates in the collateral zone during exercise, it is less likely
that inadequate epicardial artery conductance would have
limited blood flow to the normal region.
Recent evidence indicates that chronic elevations of blood
flow can increase NOS gene expression (29). In our model, the
increased flow rates in the epicardial arteries supplying the
collateral vessels might be expected to cause enhanced pro-
duction of NO. Increased dependence on NO production
could then augment the vasoconstriction that occurred when
NO production was inhibited. Miller et al. (30) found that
chronic increases in blood flow produced by a femoral arterio-
venous fistula increased both tonic and receptor-mediated
synthesis of NO in vessel rings. Furthermore, inhibition of
NOS with LNMMA resulted in enhanced vasoconstriction in
vessels with increased flow compared with that in sham-
operated control vessels. If these findings can be extended to
the coronary circulation, then the increased flow in the proxi-
mal arteries from which the collateral vessels arise could
enhance NO production, thereby augmenting the increase in
resistance after LNNA.
An increased pressure drop across the conduit vessels might
encroach on the lower limit of autoregulation of the distal
vessels. Smith and Canty (31) reported that NO contributes to
coronary autoregulation in normal awake dogs. They deter-
mined that the lower limit of autoregulation in normal dogs
was 45 mm Hg, whereas after inhibition of NOS with L-NAME,
the lower autoregulatory break point increased to 61 mm Hg.
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It is likely that this break point would be even higher during
exercise (32), thereby increasing the likelihood that perfusion
pressure could fall below the autoregulatory plateau. Thus, the
combination of an increased pressure drop across the proximal
arteries and alterations in autoregulation of the resistance
vessels might account for the reduction of myocardial blood
flow in the normal region during exercise after LNNA.
Clinical implications. A recent study using positron emis-
sion tomography in patients with single-vessel coronary artery
disease documented impaired vasodilator responses in remote
regions of normal myocardium (33). The investigators found
that myocardial blood flow at rest in the collateral-dependent
region was reduced compared with that in a group of patients
without coronary artery disease. Unexpectedly, rest blood flow
in the remote “normal” region was also reduced, and the
increases in blood flow in response to pacing and dipyridamole
were significantly impaired. Although endothelial dysfunction can
precede the appearance of angiographically evident atheroscle-
rotic disease (34) and could have contributed to the impaired
microvascular responses in that study, our results demonstrate
that coronary occlusion can cause impairment of vasodilation
in response to exercise in remote myocardial regions, even in
the absence of atherosclerotic disease.
Conclusions. NO production contributes to the mainte-
nance of coronary collateral blood flow during exercise in the
dog. In contrast to the normal heart, endogenous NO is also
important in maintaining blood flow to regions of normally
perfused myocardium during exercise in this model of single-
vessel coronary artery occlusion. This finding suggests that
control of vasomotor tone in normal myocardium is altered by
the presence of an occluded coronary artery with a region of
collateral-dependent myocardium.
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